)
)
VBI Vaccines Investor Relations Material
Latest events
Fireside Chat
VBI Vaccines
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from VBI Vaccines Inc
Access all reports
VBI Vaccines Inc., also known as Variation Biotechnologies Inc., is a biopharmaceutical company focused on the development and commercialization of vaccines for infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a commercialized hepatitis B vaccine, and has several vaccine candidates in various stages of development. These include treatments for hepatitis B, glioblastoma, cytomegalovirus, and Zika virus, along with multiple coronavirus vaccine candidates. VBI Vaccines has significant collaborations with entities like GlaxoSmithKline, the National Research Council of Canada, and the Coalition for Epidemic Preparedness Innovations. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
VBIV
Country
🇺🇸 United States